Escolar Documentos
Profissional Documentos
Cultura Documentos
Forward Programme
2008-2009
F i r s t E d i t i o n
WHO/IER/PSP/2008.04
© World Health Organization 2008
All rights reserved. Publications of the World Health Organization can be obtained from
WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Swit-
zerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int
<mailto:bookorders@who.int >). Requests for permission to reproduce or translate WHO
publications - whether for sale or for noncommercial distribution - should be addressed to
WHO Press, at the above address (fax: +41 22 791 4806; e-mail: permissions@who.int).
The designations employed and the presentation of the material in this publication do not
imply the expression of any opinion whatsoever on the part of the World Health Organi-
zation concerning the legal status of any country, territory, city or area or of its authorities,
or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent
approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that
they are endorsed or recommended by the World Health Organization in preference to
others of a similar nature that are not mentioned. Errors and omissions excepted, the names
of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by the World Health Organization to verify
the information contained in this publication. However, the published material is being
distributed without warranty of any kind, either expressed or implied. The responsibility for
the interpretation and use of the material lies with the reader. In no event shall the World
Health Organization be liable for damages arising from its use.
Printed in France
Designed by messaggio studios
World Alliance
for Patient Safety
FORWARD PROGRAMME 2008-2009
First Edition
This draft is intended for discussion at the Expert Advisory Group Meeting, 25 June 2008
About
the World Alliance
for Patient Safety
In May 2002, the Fifty-fifth World Health Assembly adopted WHA Resolution
55.18, which urged Member States to pay the closest possible attention to the
problem of patient safety and to establish and strengthen science-based systems
necessary for improving patient safety and the quality of health care.
Following this, in May 2004, the Fifty-seventh World Health Assembly supported
the creation of an international alliance to facilitate the development of patient
safety policy and practice in all Member States, to act as a major force for impro-
vement internationally.
The Patient Safety Programme within the Information, Evidence and Research Cluster
incorporates the World Alliance for Patient Safety, which addresses patient safety in
health care as an issue of global importance. It promotes the development of eviden-
ce-based norms for the delivery of safer patient care, global classifications for medical
errors and it supports knowledge sharing in patient safety between Member Sta-
tes. The Alliance advocates for a better understanding of the reasons for unsafe
care and identifies the most effective preventive measures and means of evaluating
them. It works with leading international experts, organizations, patient NGOs
and many others, to draw international attention to the issue of patient safety.
The Alliance, bi-annually, publishes its Forward Programme setting out its two-year
work programme, as well as a Progress Report detailing actions taken to deliver
its major priorities. The first edition of the 2008-2009 Forward Programme is
intended to be a discussion document to allow the Alliance Secretariat, its expert
leaders and a multitude of external stakeholders to debate the priorities that should
be addressed in the next two years.
«WHO Member States have recognized that pa-
tient safety is important. WHO’s World Alliance
for Patient Safety work is supported by a growing
number of partnerships with safety agencies, tech-
Dr Margaret Chan, nical experts, patient groups and many other stake-
Director-General, holders from around the world who are helping to
World Health
Organization drive the patient safety agenda forward.
In August 2005, Fedir Petkanych was nervous for his wife, Zoryana. In their
home in the Ukraine she was suffering excruciating headaches and high fevers.
Accompanying her to hospital, he was unable to get attention and answers
as doctors handed over her case from one team to another without a definite
diagnosis. Her diagnosis was changed five times over ten days, with a final
diagnosis of meningitis. The delay was fatal and Zoryana, a young mother with
a seven-month old child, died of her infection.
Between these two tragic episodes, which represent only two of the hundreds of
thousands of patients worldwide who have experienced serious adverse events,
the world of health care has changed. Major studies around the world have been
undertaken to explore and remediate the problem of adverse health-care events.
Partly in response to these studies and the scope of the worldwide patient safety
problem, the WHO World Alliance for Patient Safety was established in 2004. Its
goal is to mobilize global efforts to improve the safety of health-care for patients
in all WHO Member States. The Alliance’s first and second Forward Programmes
laid out an ambitious agenda in patient safety. Yet, the backdrop of Betsy’s and
Fedir’s stories should show us that, as we release this third Forward Programme,
there is a vast, unfinished agenda that still remains. We have done well at raising
awareness and assessing the problem. We need, collectively, to do better at de-
veloping and evaluating evidence and knowledge for patient safety and dissemi-
nating and supporting its use.
Assessing
and
understanding
the problem
Developing
Strengthening norms and
capacity standards
Creating
Safer
Health Care
Pr omoting Improving
innovation and knowledge
sustaining access and use
commitment
Through concerted effort in key priority areas, the World Alliance for Patient Sa-
fety aims to:
•S
upport the efforts of Member States to promote a culture of safety within their
health-care systems and develop mechanisms to enhance patient safety;
• Position patients at the heart of the international patient safety movement;
•C
atalyse political commitment and global action on areas of greatest risk to
patient’s safety through the Global Patient Safety Challenges;
•D
evelop global norms, standards and guidelines to detect and learn from
patient safety problems, to reduce risks for future patients;
•M
ake safety solutions widely available to all Member States in ways which are
as easy as possible to implement and relevant to their needs;
•D
evelop and spread knowledge about evidence-based policies and best prac-
tices in patient safety;
•B
uild consensus on common concepts and definitions of patient safety and
adverse events;
• Initiate and foster research in areas which will have most impact on safety
problems;
•E
xplore ways in which new technologies can be harnessed in the interest of
safer care;
•B
ring together partners to contribute towards knowledge development and
social mobilization;
• T arget technical work to reflect the patient safety priorities, both of developed
and developing countries.
The Global Patient Safety Challenge is galvanizing global commitment and action on a patient safety
topic which addresses a significant area of risk for all Member States.
The first Global Patient Safety Challenge, initiated in 2005, will continue its focus on health care-associated
Action area infection with the theme ‘Clean Care is Safer Care’.
1 For 2007-2008, the second Global Patient Safety Challenge is focusing on the topic of safer surgery with
the theme ‘Safe Surgery Saves Lives’.
Work on the third Global Patient Safety Challenge, 'Tackling Antimicrobial Resistance', will commence in
2009 and the Challenge will be launched in 2010.
Patients for Patient Safety is ensuring that the voice of patients is at the core of the patient safety
Action area
movement worldwide and works with other programmes to ensure that the patient voice is always
2
represented.
Action area Research for Patient Safety is facilitating an international research agenda which supports safer health
3 care in all WHO Member States.
Action area The International Classification for Patient Safety is developing an internationally acceptable system for
4 classifying patient safety information to promote more effective global learning.
Reporting and Learning for Patient Safety is promoting valid reporting, analytical and investigative to-
Action area
ols and approaches that identify sources and causes of risks in a way that promotes learning and
5
preventive action.
Action area Solutions for Patient Safety will translate knowledge into practical solutions and disseminate these solu-
6 tions internationally.
Action area The High 5s initiative will spread best practice for change in organizational, team and clinical practices
7 to improve patient safety.
Action area Technology for Patient Safety will focus on the opportunities to harness new technologies to improve
8 patient safety.
Action area Knowledge Management will work with Member States and partners to gather and share knowledge on
9 patient safety developments globally.
The Alliance will ensure that the results of the work in the State of Michigan, USA, to eliminate central
Action area
line-associated bloodstream infections is replicated in other settings, this could change the lives of tens of
10
thousands of patients worldwide, especially on intensive care patients.
Action area Education for Safer Care will develop a curricular guide for medical students as well as implementing a
11 Patient Safety Scholars programme.
Action area The Safety Prize will be an international award for excellence in the field of patient safety that will act as
12 a driver for change and improvement.
Initial work has started on the evaluation of the first Global Patient Safety Chal-
lenge ‘Clean Care is Safer Care’ and will involve an annual global event focusing
on the measurement and compliance with hand hygiene.
T
he Global Patient Safety Challenge is a flagship programme
of the World Alliance for Patient Safety. Every two years a
Challenge is formulated to galvanize global commitment and
action on a patient safety issue which addresses a significant
area of risk for all WHO Member States. The lifespan of each Chal-
lenge is dependent upon the scope of the associated work programme
with some Challenges likely to endure beyond their initial two-year
timeframe.
1. Technical
• Pilot testing: Completion of field testing of the implementation strategies of
the WHO multimodal hand hygiene improvement strategies in pilot and
complementary test sites;
• Guidelines: Finalization of the WHO Guidelines on Hand Hygiene in Health
Care and associated implementation toolkit;
• Involvement of patients: Patients will be a core feature of the revised multi-
modal improvement strategy;
• Burden of disease: Development of a database and report on the burden
of HAI;
• Evaluation: Each aspect of the first Challenge, from cost-effectiveness through
to the effectiveness of the technical, pledging and awareness-raising activities
will be subject to robust evaluation.
2. Awareness-raising
• A regional technical and advocacy workshop in the WHO Eastern Mediter-
ranean Region;
• A regional advocacy guide on Clean Care is Safer Care;
• Publications in peer-reviewed journals, both specialist and non-specialist;
• An expansion of the communications and stakeholder engagement strategy;
• A single worldwide annual event to focus attention on better hand hygiene.
An economic evaluation tool will enable health-care facilities to estimate the local
costs and benefits of implementing the hand hygiene intervention. The tool can
help answer the following crucial question: how many health care-associated
infections need to be prevented by the hand hygiene programme in order to offset
its input cost? It will provide hospital administrations with a clear indication of the
number of HAI that must be prevented by the hand hygiene programme to gene-
rate savings to the hospital. The tool will be tested and finalized during 2008.
Over the coming biennium, the first Work to develop the first ever single During 2008-2009, the programme
Global Patient Safety Challenge event to focus attention on better hand will also explore possibilities for
will work to invigorate its existing hygiene will provide an opportunity to facilitating the creation of a public-
partnerships and embark on a new connect with and strengthen collabora- private partnership related to hand
expanded strategy of engagement tion with many partners, in particular: hygiene improvement. The aim of
beyond its established reach. Such •E uropean Centre for Disease Preven- this will be to promote a campaign
engagement forms an essential part tion and Control to expand access to alcohol-based
of the programme’s future plans and handrubs worldwide, for example
•G lobal Public-Private Partnership for
priorities. ‘Clean Care is Safer Care’ through negotiation of lower prices
Handwashing with Soap
aims to overcome any perceived lack and local production of the WHO
of engagement with partners or profes- • International Alliance of Patients’ Or- formulation.
sional organizations and ensure that it ganizations
broadens its interactions beyond spe- • International Council of Nurses In addition, ‘Clean Care is Safer
cialist professional bodies. To this end, • International Federation of Infection Care’ will work with the European
the programme has commissioned an Control and its component member Society of Clinical Microbiology and
internal review of our communications societies across the developed and Infectious Diseases to share commit-
and stakeholder engagement activity. developing world ment to improve education in infection
control across Europe, as well as with
• International Federation of Red Cross
Within WHO, ‘Clean Care is Safer networks of professionals in infection
and Red Crescent Societies
Care’ aims to strengthen its existing control, sharing knowledge and
collaboration with the Patients for • International Hospital Federation raising awareness in WHO’s regions,
Patient Safety programme, and its •M édecins Sans Frontières with a particular focus in Africa.
relationships with colleagues in fields •P ublic Services International
related to health care-associated • International Save the Children
infection. In addition, it will work Alliance
to strengthen links with the regional
patient safety focal points. •W orld Council of Churches
•W orld Health Professions Alliance
Evaluation
An evaluation project focusing on outcome measures in terms of global hand
hygiene compliance will also assess the impact of the first Challenge at regional,
country, facility, health-care worker and patient levels. This evaluation involves
collaboration with the Quality and Safety Research Group, Johns Hopkins
University. Technical experts, health-care providers and interested or-
ganizations from around the world are invited to evaluate the finali-
zed version of the guidelines using the established AGREE methodology.
(http://www.agreecollaboration.org/ )
Awareness-raising activity
Efforts to promote the activities and aspirations of the first Challenge, through
both the academic and popular press, will continue, thus strengthening the case
for continued action. The regional technical and advocacy workshops concluded
with a workshop in the WHO Eastern Mediterranean Region. A regular news bul-
letin will be used to communicate effectively with stakeholders. The aim of the first
Challenge is for all professional organizations and countries in the world to em-
brace the recommendations and the philosophy of the WHO Guidelines on Hand
Hygiene in Health Care, incorporating them within local implementation strategies
and thereby increasing the likelihood of behaviour change at the bedside.
BEFORE INDUCTION OF ANAESTHESIA Before SKIN INCISION Before patient leaves operating room
This checklist is not intended to be comprehensive. additions and modifications to fit local practice are encouraged.
Test sites were invited to participate in this event to share their experience and to
demonstrate the impact of the WHO Surgical Safety Checklist (First Edition) imple-
mentation. Some attending representatives of professional societies were invited to
publicly endorse the initiative at the launch event.
Dr David Heymann,
Assistant Director-General for
Health Security and Environment
and Representative
of the Director-General
for Polio Eradication,
WHO Geneva, Switzerland
Based on the 2001 strategic plan and the conducted analysis, the following action
areas have been identified:
Rational drug use and regulation:
• Regulation targeting the misuse of anti-infective drugs (inadequate access, coun-
terfeit and substandard drugs, over-the-counter sale, direct-to-consumer adverti-
sing);
• Action to address lacking or inadequate education of health-care workers and
the general population (over-prescribing and over-demanding drugs);
• Development and enforcement of adherence to standard treatment guidelines.
Animal husbandry:
• Regulation of anti-infective drug use in animal husbandry, agriculture and
aquaculture (treatment, growth promotion).
Partnerships:
Patients for Patient Safety will continue to develop close relationships with a range of stakeholders to
actively promote patient engagement in patient safety. The programme has already developed a strong
network of collaborative associations, working with patients, family members, patients organizations,
health-care providers and national health bodies. Through workshop events in the six WHO Regions,
the programme has brought together patients and family members who have suffered harm as well as
representatives of ministries of health and health-care providers to build partnerships at the national
level. These partnerships have resulted in the creation of action plans, the setting up of organizations
and joint working between patients and professionals to tackle patient safety issues nationally. This
focus will continue in the planned workshop events over the course of the next biennium.
PFPS has linked with a variety of organizations around the world which share its vision of partnership
and patient engagement in safety, including Consumers Advancing Patient Safety, International Allian-
ce of Patient Organizations, National Patient Safety Foundation, the All-Ukrainian Council for Patients’
Rights and Security, the Canadian Patient Safety Institute and the Danish Society for Patient Safety.
Over the next two years, it is hoped that more organizations will join PFPS to support the programme
and the role of patients in tackling patient safety.
Patient engagement
Patient engagement needs to be mainstreamed across all areas of patient safety
and health care: from simply asking patients about their preferences, fostering
strong relationships and generating patient safety materials, to developing
family advisory boards, policy making and advocating for change through
partnerships with regulatory and accrediting agencies. PFPS will begin to
embed a new patient safety culture and practice in the global health care
environment.
PFPS will undertake to define patient engagement “through the patients’
eyes” and provide examples of successful initiatives and innovative concepts.
PFPS will develop a programme and tools to encourage increased patient
engagement in patient safety. This work will build on the wisdom and
perspectives of the Champion community and global experts. The programme
will ensure that patient participation is a central element in the work of the
Alliance programmes, as well as other patient safety programmes and efforts
worldwide.
30
Patients for Patient Safety activities
To deliver these goals and to ensure that the patient perspective continues to guide
global efforts to create change and provide safer health care, PFPS and its growing
network of Champions, collaborating organizations and supporters will address the
following issues.
b) Integration with the other programmes of the WHO World Alliance for Patient
Safety
•C
ontinue to strengthen PFPS involvement in all the programmes of the Alliance in
order to engage stronger patient participation in their activities;
• Integrate some of the methodologies and practices highlighted through the Pa-
tient Engagement project into each Alliance programme, encouraging the imple-
mentation of a written plan for patient engagement;
•E
stablish an active partnership with the When things go wrong project being
led by the Health Information and Quality Authority of Ireland, as well as deve-
loping guidance and tools to support patients, families and health professionals
in the aftermath of a patient safety incident.
31
follow-up and support to the current regional Champions and integration of their
work into regional strategic objectives and activities;
•S
upport the development of PFPS Regional Declarations, to be endorsed by
WHO Regional Committees in order to aid with the integration of the activities
of patients and families into the work of each WHO Regional Office;
•S
upport the WHO Regional Offices in their development of country-level PFPS
campaigns, workshops and activities.
e) Global campaign
PFPS will work with communication experts, media, patients and key health-care
stakeholders to develop a communication and awareness campaign and resour-
ces to support campaigning at international, regional, local and organizational
levels.
f) Partnership engagement
PFPS will continue to develop partnerships with individuals, organizations,
policy-makers, ministries of health, professional associations and others, to
actively promote patient engagement in patient safety. The programme will
continue to communicate regularly with partners, share information on our
activities and supporting campaigning through the participation of Patients for
Patient Safety Champions at international and national events.
g) Events
During 2008-09, PFPS will lead and/or support:
• A global Patients for Patient Safety congress;
• Regional workshops in the Western Pacific and African Regions;
• Follow-up regional PFPS events in all four other WHO Regions;
• In-country PFPS events;
•E
vents with partners, including the participation as key note speakers at major
events of Champions and PFPS Steering Group members;
•A
key workshop at the International Alliance of Patients’ Organizations (IAPO)
global congress.
32
h) Patients for Patient Safety network development
The current governance framework for PFPS and its potential for growing,
supporting and managing the network will be reviewed.
The next steps for Patients for Patient Safety will include:
• Integrating the patient voice in all Alliance programmes.
•H
olding PFPS workshops in the WHO Western Pacific and African Re-
gions.
• Supporting in-country PFPS workshops and events.
• Supporting PFPS Champions.
•D
eveloping resources and an evaluation framework for PFPS Champions in
patient engagement in patient safety.
•H
olding a congress for PFPS Champions as part of a global awareness
campaign.
33
Research
for Patient Safety
B
etter knowledge is needed to make patient care safer. WHO
estimates that tens of millions of patients worldwide suffer disa-
bling injuries or death every year due to unsafe medical care*. «More research on patient safety
Nearly one in ten patients is harmed while receiving hospital issues is desperately needed, es-
care in developed countries, and this rate may be even higher in deve- pecially in developing countries
loping countries. Studies show that additional medical expenses and and in the outpatient setting. In
hospitalization, infections acquired in hospitals, lost income, disability particular, we need research on
and litigation cost some countries between US$ 6 billion and US$ solutions for low-resource environ-
29 billion a year. Patient safety is therefore a global public health ments. In the next year, the Re-
search programme of the WHO
problem that affects all countries, regardless of their level of economic
World Alliance for Patient Safety
development. is considering and making re-
One of the research priorities for the next biennium is to bring patients’ commendations about program-
voices into the research agenda. As such, a number of Patients for Patient mes for educating patient safety
researchers, will be establishing
Safety Champions are participating in key activities, to include the patient
a small grants programme to help
perspective in the programme. Work will step up on the development stimulate research in these areas,
of tools and methodologies to enable lessons to be drawn from and will be beginning an effort
patients’ stories. to estimate the global economic
burden of patient safety.»
Currently, there is insufficient evidence about the frequency and causes
of unsafe care, which is essential to understand the extent of patient
harm and to develop solutions. More research is therefore needed to
help health-care professionals and policy-makers understand the com-
plex causes of unsafe care, and to come up with practical responses to Programme Leader:
reduce patient harm. Such research includes: Professor David Bates,
Chief, Division of General
1) m
easuring the magnitude and type of adverse events that lead to Internal Medicine, Brigham and
patient harm, Women’s Hospital, Boston, USA
2) understanding the underlying causes of harm,
3) identifying solutions to make care safer, and
4) evaluating the impact of solutions in real-life settings (Fig. 1).
* The evidence used in this section is drawn from the following document: The Research Priority
Setting Working Group of the WHO World Alliance for Patient Safety. Summary of the Evidence
on Patient Safety: Implications for Research. Geneva: World Health Organization, 2008.
Activities
The World Alliance for Patient Safety aims to foster research and facilitate the use
of research findings to improve the safety of health care and to reduce patient
harm in all WHO Member States. One of the greatest challenges is to build the
capacity to address research questions that have the greatest impact on reducing
patient harm. Since the establishment of the research programme of the World
Alliance for Patient Safety in 2005, the programme has focused on the following
activities:
e) P roviding small grant seed funding to help support researchers and to launch
promising patient safety research projects
The Alliance has set aside US$ 500 000 to fund between 20 and 30 small
research projects commencing in 2009, with an emphasis on supporting early-
to mid-career researchers in developing countries and countries with economies
in transition. The small grants will be targeted at research projects that aim to
identify, develop and evaluate local solutions to priority areas for patient safety.
The grants will be awarded on a competitive basis using a peer review process.
It is expected that this initiative will not only stimulate research on patient safety,
but will also contribute to building research capacity at the local level. It is also
envisaged that it will facilitate the spread of research information, which will help
raise awareness of patient safety issues among researchers and policy-makers, as
well as promoting greater collaboration at national and international levels.
Collaboration and active partnerships • International Clinical Epidemio- ber of leading universities, research
are some of the key words that lie at logy Network (Global, HQ-India) institutes, professional associations
the core of the work of the research • Institute of Medicine (USA) and health-care organizations and
programme. These principles are • Japanese Society for Quality and are active in Europe, South America,
encouraged through the leadership Patient Safety (Japan) the Eastern Mediterranean Region,
of the Research Advisory Council, • Johns Hopkins University (USA) South East Asia, the Western Pacific
which has approximately twenty • Joint Commission (USA) Region and Africa. These networks
members representing some of the • National Department of Health involve multidisciplinary teams from
main constituencies of patient safety (South Africa) a number of countries and have be-
and global health research in the • Thailand Health Foundation come active agents in partnering
world. These institutions are: (Thailand) with the local health authorities and
• Tohoku University School of health-care organizations to deliver
•A
gencia Nacional de Calidad del
Medicine (Japan) the patient safety agenda.
SNS (Spain)
• University of Aga Khan (Pakistan)
•A
gency for Healthcare Research The Research programme will
• University of Manchester (UK)
and Quality (USA) continue to develop relationships
•B
righam and Women’s Hospital The Research programme also with partners, including research
(USA) carries out its programme of work by institutions and research training
•B
ritish Medical Journal, (United promoting networks and encouraging organizations, quality improvement
Kingdom) collaboration. International experts and evaluative institutions and
•D
epartment of Health (United and local research teams engage expert collaborators worldwide.
Kingdom) in active research projects working
•E
uropean Commission, Research with a number of countries around
Directorate General (EU) the world. Active networks around
•H
arvard School of Public Health research projects led by the Alliance
(USA) bring together expertise from a num-
and health policies that will make care safer. A study to measure the global burden
of unsafe care has been commissioned by the Alliance to provide the evidence
for governments to take action on this silent epidemic, which until now has been
understudied and has gone largely unnoticed.
Adam Air flight 574, a Boeing 737, went data recorder and from the analysis of the re- recording, which enables data on similar in-
missing during a domestic flight to Mana- covered airplane were compared with infor- cidents to be pooled and analysed. These
do, Indonesia on 1 January 2007. The last mation in existing data systems maintained information systems make a real difference
contact was at 14:07 when the flight was by the national authorities and other data to airline safety. The Geneva-based Aircraft
en route. Initial reports indicate that the flight systems maintained by organizations like the Crashes Record Office (ACRO), which com-
changed course twice as a result of severe Commercial Aviation Safety Team (CAST) in- piles statistics on aviation accidents worldwi-
crosswinds. However, no news came until ternationally. Consequently, the results were de announced that 2007 had been the safest
the air flight data recorder was found at sea shared globally with national transportation year in aviation since 1963. Even more im-
by an Indonesian navy ship. The airplane authorities. Data on the crash were logged portantly, the data in these systems are made
had crashed there, killing all 102 people at both the national and international level publicly available to any researcher, industry
on board. The data gathered from the flight using a universal system of airline incident analyst, policy-maker or airline passenger.
Source: Aviation Accident Database. National Safety Transportation Board. http://www.ntsb.gov/ntsb/query.asp
The World Alliance for Patient Safety launched its work on Reporting During 2008 and 2009,
and Learning for Patient Safety with its first Forward Programme. the Reporting and Learning
During 2005, the Alliance worked closely with one of the world’s baseline work will serve as
experts on adverse event measurement, Professor Lucian Leape of the starting point for more
Harvard University, to develop the WHO Guidelines for Adverse in-depth work in a number of areas,
Event Reporting and Learning Systems. In 2007, the Alliance began including:
building a relationship with Johns Hopkins University and Professor
Peter Pronovost to develop a full agenda on monitoring and evaluating • F urther work on methods and tools and
the Alliance programmes. Building on the success of the guidelines, methods for data analysis, specifically with
the Alliance has facilitated collaboration between the UK National the goal of developing approaches that can
Patient Safety Agency (NPSA) and Johns Hopkins University (JHU). be used to judge safety threats and organiza-
Working with the NPSA, JHU has carried out an extensive analysis of tional resilience.
the NPSA’s national adverse event database, the largest of its kind in •D
evelopment of tools on how to use feedback
the world, to identify ways in which data such as these can be more on incident reports.
effectively used internationally to improve patient safety.
•C
ollaboration around data mining with a par-
ticular focus on analysis of free text data.
Reporting and Learning •D
evelopment of a strategic plan for interna-
website: tional collaboration on reporting and learning
http://www.who.int/patientsafety/reporting_and_learning/en/ with Member States.
For further information and to provide suggestions for future patient safety
solutions, please visit:
www.jcipatientsafety.org and
http://www.who.int/patientsafety/solutions/patientsafety/en/index.html
T
he provision of safe care continues to present daunting «JCI is proud of its continued com-
challenges around the world. To address this problem, the mitment to the World Alliance for
High 5s initiative seeks to leverage the implementation of five Patient Safety and its role in buil-
standardized patient safety solutions that would have broad ding an expert global collabora-
tive network that has been crucial
impact in preventing adverse events in health care. This initiative
to the initiative. Through the ef-
received initial funding from the Commonwealth Fund and is forts of many, we have the poten-
sponsored by the World Alliance for Patient Safety. The ini- tial to process the development of
tiative is coordinated by the WHO Collaborating Centre for standard operating protocols that
Patient Safety. It builds on the established partnership of the provide a breakthrough in furthe-
Commonwealth Fund with Australia, Canada, Germany, the Nether- ring safe care for patients.»
lands, New Zealand, the United Kingdom of Great Britain and
Northern Ireland and the United States of America.
The Action on Patient Safety: High 5s initiative aims to learn from the
systematic implementation of innovative, standardized operating pro-
tocols of five major problems impacting patient safety, over five years
in the participating Member States. Over time, this initiative will work
towards expanding the implementation of the protocols in further coun-
tries across developed and developing countries.
Dennis O’Leary,
The standardized operating protocols (SOPs) to tackle five widespread MD, Former
patient safety problems in the participating countries are: President,
• anaging concentrated injectables;
M The Joint
Commission
• Assuring medication accuracy at transitions of care; Chicago, USA
• Performance of the correct procedure at the correct body site;
• Communication during patient care handovers;
• Improved hand hygiene to prevent health care-associated infections.
WHO Collaborating
Centre for Patient Safety
Solutions, Chicago, USA
The Alliance and the WHO Collaborating Centre on Patient Safety Solutions
will develop mechanisms to share progress and lessons learned from the
implementation of this initiative with international stakeholders. The achieve-
ment of a truly active learning community on patient safety at global, national
and facility levels will be a lasting legacy of the High 5s initiative.
The seven national lead technical agencies participating with the High 5s
initiative are:
1. Australia: Australian Commission on Safety and Quality in Healthcare.
2. Canada: Canadian Patient Safety Institute
3. Germany: German Coalition for Patient Safety
4. The Netherlands: Dutch Institute for Healthcare Improvement - CBO
5. New Zealand: Population Health Directorate, Ministry of Health
6. The United Kingdom: National Patient Safety Agency
7. The United States of America: Agency for Healthcare Research and Quality
Websites
Action on patient safety – High 5s
http://www.who.int/patientsafety/solutions/highFives/en/index.html
The Joint Commission International Centre for Patient Safety – High Fives
http://www.jcipatientsafety.org/24433/
A four-week old baby hospitalized for bronchiolitis at a teaching hospital receives two doses
of the blood thinner heparin at 1000 times the intended dosage. The baby luckily survives
without serious injury, but the young faculty member caring for him is horrified and becomes
interested in studying how the incident could have happened.
The doctor is trained in epidemiology and infectious diseases, but has not worked on
problems of patient safety, so she logs on to the World Alliance for Patient Safety website
for guidance. She enters the search term ‘heparin’, and a newspaper article comes up, en-
titled «Hospital drug errors far from uncommon» that describes a series of virtually identical
incidents that occurred in the United States of America in the past year. She finds a study
published in the past month entitled «Reducing anticoagulant medication adverse events and
avoidable patient harm.» The entry provides a useful synopsis of the paper, including several
safety measures that were found to be effective, and related links. Next, she clicks onto the
«Experts» page. She is pleasantly surprised to learn that there is a pharmacologist in the
same city, at another hospital affiliated with her medical school, who is studying antibiotic-re-
lated errors. She finds several dozen researchers working on anticoagulant adverse events in
countries across the world and a grant proposal that has just been funded to study medication
errors in ten developing and transitional countries.
The doctor then downloads a copy of the research plan. She also learns that reducing the
incidence of anticoagulant adverse drug events is one of the Joint Commission’s 2008
patient safety goals, and downloads a copy of their materials. She locates and joins the
'Preventing Medication Errors' community of practice, and posts a query. It is late at night, but
she receives responses almost immediately from colleagues in both her own and other time
zones. One of them informs her that an important factor in previous incidents has been look-
alike packaging of vials of lower and higher dose preparations of the medication. Another
directs her to a website on how to investigate a defect in care. Another invites her to apply
for a small grant to conduct a mentored research study of the topic. Still another asks if she
would consider participating, as a site, in a new multi-centre project on medication errors.
The doctor responds directly to this investigator to express her enthusiasm.
How can these resources be marshalled so that knowledge and tools can be
transformed into real improvements in the safety of health care? To make
meaningful progress, information, knowledge and experts need to be available
and accessible. Care providers interested in patient safety need to know who is
doing what, where, and the latest tools and techniques that are being applied.
The World Alliance for Patient Safety is in a unique position to gather and share
knowledge on patient safety, working in partnership with Member States, via
WHO Regional and Country Offices. Fulfilling this responsibility will be enhanced
by effective knowledge management, including networking with colleagues within
WHO and among partners and stakeholders worldwide. The Alliance's work will
be informed by the principles, tools and practices of knowledge management that
enable users to create knowledge, and to share, translate and apply what they
know, in order to create value and improve effectiveness.
I
n the United States of America, over 18 million patient days wide. Scaling up such work internationally will represent
will be spent in intensive care units (ICUs) this year. For the one of the major areas of collaboration between the Alliance
majority of those, a central venous catheter (central line) will and the Quality and Safety Research Group of Johns Hop-
be used to provide medicine and fluid to keep these critically kins University.
ill patients alive. At the same time, these incredibly important
The aim is to develop a package of intervention tools and
tools are also a source of danger for these patients. An
change management strategies that are based on the Michi-
estimated 80,000 bloodstream infections are caused
gan work, adapted to other countries, so that the Michigan
annually by central venous catheters, resulting in as many
results can be matched globally.
as 28,000 deaths.
The implementation of this project exemplifies many of the
Despite these frightening numbers, little evidence has existed
core tenets of the World Alliance for Patient Safety, namely;
to date on a solution. Intensive care is incredibly complica-
producing a culture of safety, promoting education, proac-
ted and patients are at their most vulnerable, often between
tively identifying risk, encouraging teamwork, basing prac-
life and death, while they are in the care of the intensive care
tice on evidence, and above all, realizing the benefits of
team. The Keystone ICU project in the US State of Michigan,
knowledge-sharing and collaboration. Such simple strate-
was set up to provide evidence that could be used to address
gies have the potential to truly become international and the
bloodstream infections in ICUs. A team from Johns Hopkins
World Health Organization’s World Alliance for Patient Sa-
University, led by Professor Peter Pronovost, worked with the
fety plays a vital part in achieving that goal.
Michigan Health and Hospital Association to develop the ini-
tiative in over a hundred ICUs across the state from 2003 to Initial work has been developed with the Ministry of Health
2006. of Spain, involving the Spanish Sociedad Española de Me-
dicina Intensiva, Critica y Unidades Coronarias, Grupo de
The method was startlingly simple. A five-item checklist
Trabajo de Enfermedades Infecciosas (SEMICIUC) and lea-
was developed that addressed the most common causes of
ding the country-wide implementation of a strategy based
central line-associated bloodstream infection in ICUs. A com-
on the «Michigan» project. This initiative can provide valua-
prehensive change management strategy was developed
ble lessons which will serve as inputs to the definition of the
that involved intense input and leadership from the units and
Alliance’s «Matching Michigan» strategy which will be
the staff themselves. Finally, the change in infection rates
developed in 2008-2009.
itself was closely monitored. The results were startling: the
programme saved nearly 1500 lives and nearly US$ 200 With the aim of assessing feasibility, the SEMICIUC has pi-
million. Moreover, the participating ICUs reduced their cen- loted a preliminary strategy in nine hospitals. Results of the
tral line-associated bloodstream infection rates to 0%. pilot were released in April 2008 and the Alliance, Johns
Hopkins University and the Ministry of Health of Spain have
The World Alliance for Patient Safety begun a second phase of this initiative that will accomplish
two objectives in 2008. The first is to scale up the pilot of the
and Johns Hopkins University Michigan approach to other selected areas of Spain. The
The Alliance believes that if the results achieved in the State second objective is the definition of a «Matching Michigan»
of Michigan could be replicated in other settings, this could package that could be adapted and used to reduce central
change the lives of hundreds of thousands of patients world- line-associated bloodstream infections internationally.
On Knowledge Management:
35. Establishing a robust Knowledge Management programme which will help to
ensure that health-care professionals and patients have simplified access to
data and information on patient safety worldwide.